Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT1 | P42224 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | RAF1 | P04049 | 1/20 | 0.56 |
| ▸ | PDE5A | O76074 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7504811 | 0.89 | EGFR (0.61) | MAPK1HTTPDE5AMEN1KMT2A | |
| SCHEMBL7495957 | 0.86 | MEN1 (0.57) | STAT1MAPK1HTTPDE5AMEN1 | |
| SCHEMBL7500245 | 0.85 | STAT1 (0.83) | STAT1MAPK1HTTRAF1PDE5A | |
| SCHEMBL4725990 | 0.84 | MAPK1 (0.59) | STAT1MAPK1HTTRAF1PDE5A | |
| Hydrochloric Acid SCHEMBL27452405 | 0.83 | STAT1 (0.69) | STAT1MAPK1HTTRAF1PDE5A | |
| SCHEMBL7500128 | 0.82 | STAT1 (0.67) | STAT1MAPK1HTTRAF1PDE5A | |
| SCHEMBL7473060 | 0.82 | STAT1 (0.64) | STAT1MAPK1HTTRAF1PDE5A | |
| Hydrochloric Acid SCHEMBL7502866 | 0.81 | STAT1 (0.66) | STAT1MAPK1HTTRAF1PDE5A | |
| SCHEMBL13191864 | 0.81 | EGFR (0.61) | MAPK1HTTPDE5AMEN1KMT2A | |
| SCHEMBL7497208 | 0.80 | STAT1 (0.61) | STAT1MAPK1HTTRAF1PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607439-B1 | NITROGENOUS HETEROCYCLIC COMPOUND | EISAI CO LTD (JP) | 2002-01-09 | — | — | EP | disclosed |
| US-6046206-A | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives | CELL PATHWAYS, INC. (US) | 2000-04-04 | — | — | US | disclosed |
| US-5801180-A | ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | EISAI CO., LTD. (JP) | 1998-09-01 | — | — | US | disclosed |
| US-5693652-A | Benzimidazoles for ischemic heart conditions | EISAI CO., LTD. (JP) | 1997-12-02 | — | — | US | disclosed |
| US-5576322-A | Anti-ischemic 2,4-diaminoquinazolines | EISAI CO., LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0607439-A1 | NITROGENOUS HETEROCYCLIC COMPOUND | Eisai Co., Ltd. (JP) | 1994-07-27 | — | — | EP | disclosed |